文献速递小儿神经外科与脑积水神经重症

银涂层脑室造瘘导管未降低临床诊断的脑室炎发生率

Silver-Coated Ventriculostomy Catheters Do Not Reduce Rates of Clinically Diagnosed Ventriculitis.
PubMed 文献 · World Neurosurg · 2018-06-18

该回顾性研究在1年内将临床常规从非涂层导管改为银涂层脑室外引流导管,比较两组脑室炎发生率。296例患者中非涂层组186例、银涂层组110例,脑室炎治疗率分别为21.0%和15.5%(P=0.242),银涂层未减少培养阳性率,也未减少脑脊液分流置管、抗生素使用天数、EVD留置天数或ICU住院天数。

要点

  • 银涂层EVD组脑室炎治疗率15.5%,非涂层组21.0%,差异无统计学意义(P=0.242)
  • 银涂层未降低培养阳性率,也未减少分流置管、抗生素天数、EVD天数或ICU天数
  • EVD治疗时长是脑室炎唯一显著危险因素

核心结论

  • 既往报告的银涂层EVD杀菌效果未能改变临床病程以显著减少脑室炎治疗例数。
  • 引入银涂层EVD不能以减少抗生素使用或缩短住院时间为由。

研究设计与样本

  • 回顾性研究,在1年内临床常规从置入非涂层导管改为银涂层导管,按导管类型比较患者组间脑室炎发生率。
  • 共296例患者,非涂层导管186例,银涂层导管110例。
  • 脑室炎定义为因临床怀疑而启动抗生素治疗的病例。

主要发现

  • 296例中18.9%因脑室炎接受治疗,非涂层组21.0% vs 银涂层组15.5%(P=0.242)。
  • 银涂层未降低培养阳性率。
  • EVD治疗时长是脑室炎唯一显著危险因素。
  • 银涂层导管未减少脑脊液分流置管需求、抗生素使用天数、EVD留置天数或ICU住院天数。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Ventriculitis is a serious complication when using external ventricular drains (EVDs). Bactericidal silver coating has been reported to reduce risk of infection. In the clinical setting, the diagnosis is often made based on symptoms and analyses of cerebrospinal fluid, with treatment initiated before infection is verified by culture. The bactericidal effect might not correlate with a reduced rate of clinically diagnosed infections. This retrospective study aimed to analyze if use of silver-coated EVDs is associated with a reduced rate of ventriculitis. METHODS: During 1 year, clinical routine was changed from inserting noncoated catheters to silver-coated catheters. Rate of ventriculitis was compared between patient groups based on catheter type. To examine the clinical impact of silver coating, ventriculitis was defined as cases where antibiotic treatment was initiated on clinical suspicion. RESULTS: Among 296 patients (186 noncoated and 110 silver-coated catheters), 18.9% were treated for ventriculitis, with 21.0% in the noncoated group and 15.5% in the silver-coated group (P = 0.242). Silver coating did not reduce the rate of positive cultures. Duration of EVD treatment was the single significant risk factor for ventriculitis. Silver-coated catheters did not reduce the need for cerebrospinal fluid shunt placement, days with antibiotics, days with EVD, or days in the intensive care unit. CONCLUSIONS: The previously reported bactericidal effect of silver-coated EVDs did not alter the clinical course to significantly reduce the number of treated cases of ventriculitis. The introduction of silver-coated EVDs cannot be motivated by reduced use of antibiotics or shorter hospital stay.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Nilsson A, Uvelius E, Cederberg D, et al. Silver-Coated Ventriculostomy Catheters Do Not Reduce Rates of Clinically Diagnosed Ventriculitis. World Neurosurg. 2018. PMID: 29920387. doi:10.1016/j.wneu.2018.06.045

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。